Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Adial Pharmaceuticals Inc
ADIL | US
1.58
USD0.02
1.28%
ADIL | US
Loading StockChartView...
About Adial Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
1.58
Open
1.57
High
1.59
Low
1.55
Adial Pharmaceuticals Inc. a clinical-stage biopharmaceutical company focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04 a serotonin-3 antagonist which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals Inc. was founded in 2010 and is based in Charlottesville Virginia.
View LessADIL | US
Risk
46.8
Sharpe
-0.71
Luna's Score
39/100
Recommendation
Sell
Luna says (ADIL | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
20.8%1 month
46.8%3 months
88.3%6 months
74.3%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.45
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-0.49
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-7.27M
MarketCap
10.12M
MarketCap(USD)
10.12M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-320.96
Short ratio
0.72
Short perc.
1.24
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.19
Range1M
0.38
Range3M
3.54
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.61
Price X volume
93.41K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.49 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 1.45 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 88.31 | 72.80 | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 10.12M | 3.66B | Emerging |
